Awards and Prizes
The FNIH manages several prestigious prizes recognizing exceptional scientific achievement – motivating researchers, elevating important discoveries into the broader public’s awareness and inspiring the next generation to pursue careers in biomedical research.
Noted donors established these prizes to enrich both the important contributions to the scientific community and the mission of the FNIH. Below are just a few examples of these important initiatives.
The Lurie Prize in Biomedical Sciences recognizes outstanding achievements by a promising early-career scientist. Funded by philanthropist Ann Lurie, the prize has recognized scientific excellence in biomedical research since 2013, and many recipients have gone on to win other major international prizes. For example, the 2014 Lurie Prize recipient, Dr. Jennifer Doudna, was awarded the 2020 Nobel Prize for her work developing CRISPR genome editing technology. This year, nominations open in July for the 2022 Lurie Prize – marking the Lurie Prize’s tenth anniversary.
"This prize was created to highlight outstanding achievements and ingenuity by a promising early-career scientist in biomedical research, and this year’s winner is no exception. She’s something special – her work will push humanity forward and create unparalleled medical solutions for decades to come.”
Ann Lurie, Philanthropist, speaking about the 2020 Lurie Prize Winner Dr. Aviv Regev.
Established in 2018, the FNIH’s Trailblazer Prize for Clinician-Scientists recognizes outstanding contributions of early career clinician-scientists whose work has the potential to lead to, or has led to innovations in patient care. The 2020 recipient, Dr. Michael Wilson of the University of California San Francisco, pioneered a next-generation diagnostic approach to pinpoint infectious causes of inflammatory conditions of the central nervous system.
The Charles A. Sanders, M.D., Partnership Award recognizes persons or organizations that have made significant contributions to the FNIH’s work to build, implement and nurture private-public partnerships in support of the mission of the NIH. The 2020 Partnership Award was presented to Dr. Anthony Fauci, the Director of the National Institute of Allergy and Infectious Diseases.
The Deeda Blair Research Initiative for Disorders of the Brain awards fellowships to top mental health researchers and clinicians with the goal of serving as a catalyst for bold medical research and scientific breakthroughs to advance the diagnosis and treatment of mental illness. In 2020, the Research Initiative’s incipient awards went to early-career mental health researcher’s, Dr. Christopher Barley of the University of California San Francisco, Dr. Sarah Fineberg of Yale University, and Dr. David Ross of the National Neuroscience Curriculum Initiative at Yale University.
While cutting-edge neuroscience research has the potential to transform the field of psychiatry, we are currently held back by the failure to translate these findings into our educational settings and into everyday clinical practice. Funding to the National Neuroscience Curriculum Initiative from the Deeda Blair Research Initiative for Disorders of the Brain – along with matching gifts from the Society of Biological Psychiatry and the American College of Neuropsychopharmacology – will create a new framework for addressing this critical need. This award will have a transformative impact, allowing us to expand on our previous work and pursue a broader mission: to bring neuroscience literacy to all mental health providers and, in turn, to improve our dialogue with patients, families, and the public."
--Dr. David Ross, National Neuroscience Curriculum Initiative, Yale University School of Medicine, 2020 Deeda Blair Research Initiative Award recipient
To learn about other awards or ways to recognize outstanding scientific achievement, please contact email@example.com.